Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes
Author(s) -
Mateu Espasa,
Julian GonzálezMartin,
Fernando Alcaide,
Lina Marcela Aragón,
J. Lonca,
Joxe Mari Manterola,
Margarita Salvadó,
Griselda Tudó,
Pilar Orús,
Pere Coll
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki132
Subject(s) - rifampicin , isoniazid , mycobacterium tuberculosis , microbiology and biotechnology , tuberculosis , virology , biology , gene , antibacterial agent , antibiotics , medicine , genetics , pathology
This study evaluates a method based on real-time PCR for direct detection in clinical samples of the common mutations responsible for isoniazid and rifampicin resistance of Mycobacterium tuberculosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom